2018 will be another busy year for the UroGPO network. UroGPO has launched initiatives to prepare groups for new therapies on the horizon for advanced cancers (M0 CRPC, bladder and renal), and is actively deploying operational resources for existing therapies in BPH, OAB and Peyronie’s disease. From guideline development to Champions-based educational programs to virtual events, 2018 will further our commitment to driving value for UroGPO network members. We look forward to continuing a partnership that helps your practices deliver effective urology patient care and practice success.